The Impact of the Use of the MAURISSE Application in People Suffering From

Status Recruiting

Clinical Trial Summary

Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care attrition and mistrust towards care. Considering this, establishing a strong, trustful relationship between the patient and the healthcare team is important to promote patient engagement within SUD management. However, it requires an important availability of the healthcare team, allowing for frequent interactions at all times, including at night and during days off. We postulated that a mobile application called MAURISSE, which aims to help the caregivers maintaining a link with the patient in order to facilitate trust in the relationship, could foster patient engagement as well as the therapeutic alliance. This research aims to compare the effect of the application MAURISSE on the therapeutic alliance in a population of patients treated for a disorder related to substance use at the Toulouse University Hospital.

Clinical Trial Description

Substance Use Disorders (SUD) are frequently associated with other mental disorders, especially Borderline Personality Disorder, thus defining co-occurring substance use and mental disorders with borderline and anti-social personality disorders that is often associated with cognitive schemas leading to care attrition and mistrust towards care. The goal of the care intervention within Substance Use Disorders management is therefore to help the patient reduce the use of dysfunctional coping strategies involving substance use. Indeed, the establishment of a trustful relation between the patient and the care team leads the patient into building a secure attachment towards care that could secondly be generalized in other situations. We designed an application called MAURISSE, which aims to help the caregivers maintaining a link with the patient in order to facilitate a more secure attachment, thus enabling trust in the relationship as well as fostering patient engagement in the care. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05964296
Study type	Interventional
Source	University Hospital, Toulouse
Contact	Juliette SALLES
Phone	05 61 77 73 07
Email	salles.j@chu-toulouse.fr
Status	Recruiting
Phase	N/A
Start date	September 7, 2023
Completion date	March 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06367907` - Biological Effects of Schema Therapy	N/A
Completed	`NCT02518906` - Evaluation of AIT Study	N/A
Not yet recruiting	`NCT02126787` - Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment	N/A
Terminated	`NCT00353379` - Pharmacology of Cognition in Schizotypal Personality Disorder	Phase 4
Active, not recruiting	`NCT05018312` - Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety	N/A
Completed	`NCT04466163` - Strengthening the Healthy Adult Mode: a Case Experimental Study Exploring the Effects of a New Schema Therapy Protocol in an Adult Outpatient Population.	N/A
Not yet recruiting	`NCT03608449` - Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System	N/A
Recruiting	`NCT06415812` - Evolutionary Systems Therapy for Personality Pathology	N/A
Completed	`NCT05601063` - Ascertaining Diagnosis Classification With Elicited Speech
Completed	`NCT03768674` - Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway
Completed	`NCT02308462` - Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents	N/A
Terminated	`NCT00400933` - Evaluation of a Six-session Psycho-education Group Program	Phase 1
Completed	`NCT04694482` - The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
Recruiting	`NCT05503745` - MICBT for Non-underweight Adults With Eating Disorders	N/A
Completed	`NCT01428349` - Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates	N/A
Active, not recruiting	`NCT00378248` - Ullevål PersonalityProject	N/A
Recruiting	`NCT06182787` - Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
Completed	`NCT02573246` - Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study	N/A
Not yet recruiting	`NCT02397187` - Efficacy of a Structured, Dimension-based, STI in De-compensated Personality-disorder, Hospitalized, Patients	N/A
Completed	`NCT00458094` - Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Impact of the Use of the MAURISSE Application in People Suffering From an Addiction. — ALMA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms